910O Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)
Cohen, E.E., Ferris, R.L., Psyrri, A., Haddad, R., Tahara, M., Bourhis, J., Harrington, K.J., Chang, P.M-H., Lin, J-C., Razaq, M., Teixeira, M.M., Lovey, J., Chamois, J., Rueda Dominguez, A., Hu, C.,Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.1025
Date:
September, 2020
File:
PDF, 147 KB
2020